AU4970193A - IPNV vaccine - Google Patents

IPNV vaccine

Info

Publication number
AU4970193A
AU4970193A AU49701/93A AU4970193A AU4970193A AU 4970193 A AU4970193 A AU 4970193A AU 49701/93 A AU49701/93 A AU 49701/93A AU 4970193 A AU4970193 A AU 4970193A AU 4970193 A AU4970193 A AU 4970193A
Authority
AU
Australia
Prior art keywords
ipnv vaccine
ipnv
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49701/93A
Inventor
Robert Vincent Fishleigh
Paul John Greaney
Barry Robson
Ann Patricia Shakespeare
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Protherics Medicines Development Ltd
Original Assignee
Proteus Molecular Design Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929218163A external-priority patent/GB9218163D0/en
Priority claimed from GB929219710A external-priority patent/GB9219710D0/en
Application filed by Proteus Molecular Design Ltd filed Critical Proteus Molecular Design Ltd
Publication of AU4970193A publication Critical patent/AU4970193A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU49701/93A 1992-08-26 1993-08-25 IPNV vaccine Abandoned AU4970193A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB929218163A GB9218163D0 (en) 1992-08-26 1992-08-26 Synthetic polypeptides
GB9218163 1992-08-26
GB9219710 1992-09-17
GB929219710A GB9219710D0 (en) 1992-09-17 1992-09-17 Synthetic polypeptides
PCT/GB1993/001812 WO1994004565A2 (en) 1992-08-26 1993-08-25 Ipnv vaccine

Publications (1)

Publication Number Publication Date
AU4970193A true AU4970193A (en) 1994-03-15

Family

ID=26301496

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49701/93A Abandoned AU4970193A (en) 1992-08-26 1993-08-25 IPNV vaccine

Country Status (3)

Country Link
CN (1) CN1090584A (en)
AU (1) AU4970193A (en)
WO (1) WO1994004565A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2143823C (en) * 1992-08-27 2005-07-26 Alfio Comis Retro-, inverso - and retro-inverso synthetic peptide analogues
TW201139672A (en) * 2002-12-13 2011-11-16 Novartis Ag Immunization of fish with plant-expressed recombinant proteins
GB201400311D0 (en) * 2014-01-08 2014-02-26 Aqua Gen As Treating Susceptibility
AU2014400580A1 (en) * 2014-07-11 2017-02-16 Fundacion Fraunhofer Chile Research Agent with antiviral properties for preventing or treating individuals exposed to a virus of the Birnaviridae family

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991003570A1 (en) * 1989-09-04 1991-03-21 Sapporo Breweries Limited Monoclonal antibody against infectious pancreatic nephrosis virus having neutralizing activity

Also Published As

Publication number Publication date
WO1994004565A2 (en) 1994-03-03
CN1090584A (en) 1994-08-10
WO1994004565A3 (en) 1994-06-09

Similar Documents

Publication Publication Date Title
CZ197595A3 (en) Vaccine preparations
AP9300541A0 (en) Vaccines
AU3888793A (en) Novel medicament
AU4166393A (en) Auto-reclosers
AU3561193A (en) TNF-muteins
AU3991693A (en) Pyrazinoindoles
AU4177593A (en) Benzophenonehydrazones
AU3950193A (en) Cannula
AU3263493A (en) Tonometer
AU5737494A (en) Human thrombospondin-4
AU3562193A (en) Morpholin- and thiomorpholin-4-ylamides
AU3461693A (en) Saddle-cloth
AU4164793A (en) Heterocyclyltriazolinones
AU5959494A (en) Vaccines against sterols
AU4970193A (en) IPNV vaccine
GB9215233D0 (en) Vaccines
AU3185693A (en) Pyrrolylbenzodiazepinones
GB9201023D0 (en) Vaccines
GB9214871D0 (en) Vaccines
GB9213559D0 (en) Vaccines
AU4762993A (en) Keratometer
GB9202933D0 (en) Vaccines
AU6409894A (en) Recognin vaccines
AU1851392A (en) Ccv vaccine
GB9226768D0 (en) Vaccines